Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing bronchodilator therapy in emphysema.

Philip T Diaz1, Aaron S Bruns, Michael E Ezzie

  • 1Department of Medicine, The Ohio State University Medical Center, Columbus, OH 43210, USA. philip.diaz@osumc.edu

Proceedings of the American Thoracic Society
|May 6, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Occupational Exposure to Dust and Fumes Increases Risk for Future Adverse Clinical Outcomes.

American journal of respiratory and critical care medicine·2026
Same author

Stiffness-dependent alveolar type II cell senescence in idiopathic pulmonary fibrosis.

Cell communication and signaling : CCS·2026
Same author

Sotatercept in Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension: A Case Series and Systematic Review.

Pulmonary circulation·2026
Same author

Effect of a self-directed lifestyle-based weight management program among patients with comorbid COPD and sleep apnea: a secondary analysis of the INSIGHT COPD trial.

Annals of the American Thoracic Society·2025
Same author

Management of Multifocal Benign Acquired Bronchoesophageal Fistulas.

Innovations (Philadelphia, Pa.)·2025
Same author

Randomized Sham-controlled Trial of Targeted Lung Denervation in Patients with Chronic Obstructive Pulmonary Disease (AIRFLOW-3).

American journal of respiratory and critical care medicine·2025
Same journal

Note from the editor.

Proceedings of the American Thoracic Society·2012
Same journal

Adaptation, evaluation, and updating of guidelines: article 14 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Proceedings of the American Thoracic Society·2012
Same journal

Disseminating and implementing guidelines: article 13 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Proceedings of the American Thoracic Society·2012
Same journal

Reporting and publishing guidelines: article 12 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Proceedings of the American Thoracic Society·2012
Same journal

Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Proceedings of the American Thoracic Society·2012
Same journal

How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Proceedings of the American Thoracic Society·2012
See all related articles

This review examines bronchodilators for chronic obstructive pulmonary disease (COPD) management. It focuses on combination therapy to optimize treatment for improved lung function and quality of life.

Area of Science:

  • Pulmonology
  • Pharmacology

Background:

  • Chronic obstructive pulmonary disease (COPD) management aims to alleviate symptoms, slow lung function decline, and enhance quality of life.
  • Bronchodilators are foundational in COPD treatment guidelines.
  • Available bronchodilator classes include beta-agonists, anticholinergics, and phosphodiesterase inhibitors, each with distinct mechanisms.

Purpose of the Study:

  • To review the pharmacologic properties of various bronchodilators.
  • To examine recent studies on combination bronchodilator therapy for stable COPD.

Main Methods:

  • Literature review of pharmacologic properties of bronchodilators.
  • Analysis of recent clinical studies on combination therapy in COPD.

Main Results:

Related Experiment Videos

  • Stepwise treatment escalation is standard for stable COPD.
  • Combining different bronchodilator classes is often necessary due to COPD's progressive nature.
  • Recent studies explore optimizing COPD treatment through combination therapy.

Conclusions:

  • Bronchodilator selection and combination are key to effective COPD management.
  • Combination therapy holds promise for optimizing treatment outcomes in COPD.
  • Further research on bronchodilator combinations can improve patient care.